Evidence map›Paper›PMID 38625909›Full record

ArticlePloS one2024

Learning epistatic polygenic phenotypes with Boolean interactions.

Merle Behr, Karl Kumbier, Aldo Cordova-Palomera, Matthew Aguirre, Omer Ronen, Chengzhong Ye, Euan Ashley, Atul J Butte, Rima Arnaout, Ben Brown and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. A simplified MyProstateScore2.0 for high-grade prostate cancer.Cancer biomarkers : section A of Disease markers · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Merle BehrFaculty of Informatics and Data Science, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-4255-5237
Karl KumbierDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, United States of America.
Aldo Cordova-PalomeraDepartment of Pediatrics, Stanford Medicine, Stanford, CA, United States of America.
Matthew AguirreDepartment of Pediatrics, Stanford Medicine, Stanford, CA, United States of America.
Omer RonenDepartment of Statistics, University of California at Berkeley, Berkeley, CA, United States of America.
Chengzhong YeDepartment of Statistics, University of California at Berkeley, Berkeley, CA, United States of America.
Euan AshleyDivision of Cardiovascular Medicine, Stanford Medicine, Stanford, CA, United States of America.
Atul J ButteBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, United States of America.ORCID 0000-0002-7433-2740
Rima ArnaoutBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, United States of America.
Ben BrownDepartment of Statistics, University of California at Berkeley, Berkeley, CA, United States of America.
James PriestDepartment of Pediatrics, Stanford Medicine, Stanford, CA, United States of America.ORCID 0000-0002-2505-617X
Bin YuDepartment of Statistics, University of California at Berkeley, Berkeley, CA, United States of America.ORCID 0000-0002-8888-4060
Stanford Medicine · USUniversity of California, Berkeley · USUniversity of California, San Francisco · USLawrence Berkeley National Laboratory · USUniversity of Regensburg · DE

Funding

POSTDOCTORAL TRAINING IN MEDICAL INFORMATION SCIENCEST15LM007033 · NLM · STANFORD UNIVERSITY · PI SYLVIA KATINA PLEVRITIS · 1985 to 2026
$25.5M
Toward efficient performance for deep learning on medical imagingR01HL150394 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Rima Arnaout · 2020 to 2026
$6.2M
Genetics and Structure of Trabecular Myocardium in Development and DiseaseK08HL125945 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARNAOUT, RIMA · 2015 to 2019
$863k
NHLBI NIH HHS K08 HL125945NHLBI NIH HHS R01 HL150394NLM NIH HHS T15 LM007033
6 · The paper itself

Abstract

Detecting epistatic drivers of human phenotypes is a considerable challenge. Traditional approaches use regression to sequentially test multiplicative interaction terms involving pairs of genetic variants. For higher-order interactions and genome-wide large-scale data, this strategy is computationally intractable. Moreover, multiplicative terms used in regression modeling may not capture the form of biological interactions. Building on the Predictability, Computability, Stability (PCS) framework, we introduce the epiTree pipeline to extract higher-order interactions from genomic data using tree-based models. The epiTree pipeline first selects a set of variants derived from tissue-specific estimates of gene expression. Next, it uses iterative random forests (iRF) to search training data for candidate Boolean interactions (pairwise and higher-order). We derive significance tests for interactions, based on a stabilized likelihood ratio test, by simulating Boolean tree-structured null (no epistasis) and alternative (epistasis) distributions on hold-out test data. Finally, our pipeline computes PCS epistasis p-values that probabilisticly quantify improvement in prediction accuracy via bootstrap sampling on the test set. We validate the epiTree pipeline in two case studies using data from the UK Biobank: predicting red hair and multiple sclerosis (MS). In the case of predicting red hair, epiTree recovers known epistatic interactions surrounding MC1R and novel interactions, representing non-linearities not captured by logistic regression models. In the case of predicting MS, a more complex phenotype than red hair, epiTree rankings prioritize novel interactions surrounding HLA-DRB1, a variant previously associated with MS in several populations. Taken together, these results highlight the potential for epiTree rankings to help reduce the design space for follow up experiments.

Indexed as

Epistasis, GeneticGenome-Wide Association StudyHumansLogistic ModelsMultifactorial InheritancePhenotypePolymorphism, Single Nucleotide

Identifiers

PMID38625909
PMCPMC11020961
OpenAlexW4394841574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.